AAPL329.27-3.75 (-1.13%) ▼|ABBV260.64-0.96 (-0.37%) ▼|ABT97.47-1.37 (-1.38%) ▼|ACN216.39+33.02 (+18.00%) ▲|ADBE241.59+1.65 (+0.69%) ▲|AMAT529.73+18.35 (+3.59%) ▲|AMD616.71+4.95 (+0.81%) ▲|AMGN410.16-11.35 (-2.69%) ▼|AMT161.43-2.27 (-1.38%) ▼|AMZN249.21+0.06 (+0.02%) ▲|AVGO348.91-2.29 (-0.65%) ▼|AXP300.50-3.60 (-1.18%) ▼|BA189.54+3.49 (+1.87%) ▲|BAC53.73-0.71 (-1.30%) ▼|BKNG161.10-1.81 (-1.11%) ▼|BLK1,070.35+12.06 (+1.14%) ▲|BMY61.52-0.88 (-1.41%) ▼|BNY143.51-1.12 (-0.77%) ▼|BRK-B498.93+0.98 (+0.20%) ▲|C127.22-2.26 (-1.75%) ▼|CAT826.28+15.49 (+1.91%) ▲|CL84.53-0.80 (-0.93%) ▼|CMCSA21.75-0.02 (-0.07%) ▼|COF193.10+0.03 (+0.02%) ▲|COP126.61+1.46 (+1.17%) ▲|COST916.99+6.65 (+0.73%) ▲|CRM234.66+5.09 (+2.22%) ▲|CSCO108.45+0.82 (+0.76%) ▲|CVS85.52-0.17 (-0.20%) ▼|CVX206.49+2.28 (+1.12%) ▲|DE662.60-8.95 (-1.33%) ▼|DHR213.26-8.29 (-3.74%) ▼|DIS101.55-3.35 (-3.19%) ▼|DUK113.64-0.38 (-0.33%) ▼|EMR157.67+2.57 (+1.66%) ▲|FDX286.99+1.90 (+0.66%) ▲|GD333.06+1.23 (+0.37%) ▲|GE312.56+0.27 (+0.08%) ▲|GEV990.35+39.86 (+4.19%) ▲|GILD147.82-1.23 (-0.83%) ▼|GM78.10+1.10 (+1.43%) ▲|GOOG336.08-4.67 (-1.37%) ▼|GOOGL339.32-4.76 (-1.38%) ▼|GS896.34-4.02 (-0.45%) ▼|HD281.58-2.91 (-1.02%) ▼|HON213.64+2.70 (+1.28%) ▲|IBM227.97+8.04 (+3.66%) ▲|INTC121.35+1.12 (+0.93%) ▲|INTU283.23+7.52 (+2.73%) ▲|ISRG401.47-5.17 (-1.27%) ▼|JNJ258.61-6.14 (-2.32%) ▼|JPM332.51+1.68 (+0.51%) ▲|KO85.80-0.29 (-0.33%) ▼|LIN468.57-6.08 (-1.28%) ▼|LLY1,140.46-16.63 (-1.44%) ▼|LMT506.45-2.80 (-0.55%) ▼|LOW182.12-2.18 (-1.18%) ▼|LRCX337.28+8.77 (+2.67%) ▲|MA549.46-2.01 (-0.36%) ▼|MCD231.33+0.39 (+0.17%) ▲|MDLZ57.71-0.11 (-0.19%) ▼|MDT85.58-0.72 (-0.83%) ▼|META728.48+3.30 (+0.45%) ▲|MMM162.69-1.47 (-0.89%) ▼|MO66.84-0.51 (-0.75%) ▼|MRK143.53-1.78 (-1.23%) ▼|MS187.18-0.91 (-0.48%) ▼|MSFT515.47+2.57 (+0.50%) ▲|MU1,091.50+26.39 (+2.48%) ▲|NEE76.30+0.56 (+0.73%) ▲|NFLX68.33-1.25 (-1.80%) ▼|NKE35.93+0.53 (+1.50%) ▲|NOW137.73+3.72 (+2.77%) ▲|NVDA230.76+2.38 (+1.04%) ▲|ORCL138.81+1.51 (+1.10%) ▲|PEP125.81-0.91 (-0.72%) ▼|PFE28.18-0.34 (-1.20%) ▼|PG144.15-1.13 (-0.78%) ▼|PLTR189.53+2.48 (+1.32%) ▲|PM187.40-3.43 (-1.79%) ▼|QCOM185.01+0.97 (+0.53%) ▲|RTX184.90-0.75 (-0.40%) ▼|SBUX94.35+0.39 (+0.42%) ▲|SCHW98.05+0.31 (+0.31%) ▲|SO83.20+0.31 (+0.37%) ▲|SPG200.15-0.62 (-0.31%) ▼|T24.38-0.03 (-0.10%) ▼|TMO657.40-17.65 (-2.61%) ▼|TMUS161.98-1.10 (-0.67%) ▼|TSLA355.81+1.00 (+0.28%) ▲|TXN281.30+1.21 (+0.43%) ▲|UBER67.98-0.54 (-0.78%) ▼|UNH364.69-2.39 (-0.65%) ▼|UNP270.44-1.69 (-0.62%) ▼|UPS93.99+0.55 (+0.58%) ▲|USB56.77-1.00 (-1.72%) ▼|V358.96-0.37 (-0.10%) ▼|VZ46.01+0.14 (+0.29%) ▲|WFC79.51-0.54 (-0.67%) ▼|WMT104.87+0.95 (+0.91%) ▲|XOM163.83+1.08 (+0.66%) ▲|AAPL329.27-3.75 (-1.13%) ▼|ABBV260.64-0.96 (-0.37%) ▼|ABT97.47-1.37 (-1.38%) ▼|ACN216.39+33.02 (+18.00%) ▲|ADBE241.59+1.65 (+0.69%) ▲|AMAT529.73+18.35 (+3.59%) ▲|AMD616.71+4.95 (+0.81%) ▲|AMGN410.16-11.35 (-2.69%) ▼|AMT161.43-2.27 (-1.38%) ▼|AMZN249.21+0.06 (+0.02%) ▲|AVGO348.91-2.29 (-0.65%) ▼|AXP300.50-3.60 (-1.18%) ▼|BA189.54+3.49 (+1.87%) ▲|BAC53.73-0.71 (-1.30%) ▼|BKNG161.10-1.81 (-1.11%) ▼|BLK1,070.35+12.06 (+1.14%) ▲|BMY61.52-0.88 (-1.41%) ▼|BNY143.51-1.12 (-0.77%) ▼|BRK-B498.93+0.98 (+0.20%) ▲|C127.22-2.26 (-1.75%) ▼|CAT826.28+15.49 (+1.91%) ▲|CL84.53-0.80 (-0.93%) ▼|CMCSA21.75-0.02 (-0.07%) ▼|COF193.10+0.03 (+0.02%) ▲|COP126.61+1.46 (+1.17%) ▲|COST916.99+6.65 (+0.73%) ▲|CRM234.66+5.09 (+2.22%) ▲|CSCO108.45+0.82 (+0.76%) ▲|CVS85.52-0.17 (-0.20%) ▼|CVX206.49+2.28 (+1.12%) ▲|DE662.60-8.95 (-1.33%) ▼|DHR213.26-8.29 (-3.74%) ▼|DIS101.55-3.35 (-3.19%) ▼|DUK113.64-0.38 (-0.33%) ▼|EMR157.67+2.57 (+1.66%) ▲|FDX286.99+1.90 (+0.66%) ▲|GD333.06+1.23 (+0.37%) ▲|GE312.56+0.27 (+0.08%) ▲|GEV990.35+39.86 (+4.19%) ▲|GILD147.82-1.23 (-0.83%) ▼|GM78.10+1.10 (+1.43%) ▲|GOOG336.08-4.67 (-1.37%) ▼|GOOGL339.32-4.76 (-1.38%) ▼|GS896.34-4.02 (-0.45%) ▼|HD281.58-2.91 (-1.02%) ▼|HON213.64+2.70 (+1.28%) ▲|IBM227.97+8.04 (+3.66%) ▲|INTC121.35+1.12 (+0.93%) ▲|INTU283.23+7.52 (+2.73%) ▲|ISRG401.47-5.17 (-1.27%) ▼|JNJ258.61-6.14 (-2.32%) ▼|JPM332.51+1.68 (+0.51%) ▲|KO85.80-0.29 (-0.33%) ▼|LIN468.57-6.08 (-1.28%) ▼|LLY1,140.46-16.63 (-1.44%) ▼|LMT506.45-2.80 (-0.55%) ▼|LOW182.12-2.18 (-1.18%) ▼|LRCX337.28+8.77 (+2.67%) ▲|MA549.46-2.01 (-0.36%) ▼|MCD231.33+0.39 (+0.17%) ▲|MDLZ57.71-0.11 (-0.19%) ▼|MDT85.58-0.72 (-0.83%) ▼|META728.48+3.30 (+0.45%) ▲|MMM162.69-1.47 (-0.89%) ▼|MO66.84-0.51 (-0.75%) ▼|MRK143.53-1.78 (-1.23%) ▼|MS187.18-0.91 (-0.48%) ▼|MSFT515.47+2.57 (+0.50%) ▲|MU1,091.50+26.39 (+2.48%) ▲|NEE76.30+0.56 (+0.73%) ▲|NFLX68.33-1.25 (-1.80%) ▼|NKE35.93+0.53 (+1.50%) ▲|NOW137.73+3.72 (+2.77%) ▲|NVDA230.76+2.38 (+1.04%) ▲|ORCL138.81+1.51 (+1.10%) ▲|PEP125.81-0.91 (-0.72%) ▼|PFE28.18-0.34 (-1.20%) ▼|PG144.15-1.13 (-0.78%) ▼|PLTR189.53+2.48 (+1.32%) ▲|PM187.40-3.43 (-1.79%) ▼|QCOM185.01+0.97 (+0.53%) ▲|RTX184.90-0.75 (-0.40%) ▼|SBUX94.35+0.39 (+0.42%) ▲|SCHW98.05+0.31 (+0.31%) ▲|SO83.20+0.31 (+0.37%) ▲|SPG200.15-0.62 (-0.31%) ▼|T24.38-0.03 (-0.10%) ▼|TMO657.40-17.65 (-2.61%) ▼|TMUS161.98-1.10 (-0.67%) ▼|TSLA355.81+1.00 (+0.28%) ▲|TXN281.30+1.21 (+0.43%) ▲|UBER67.98-0.54 (-0.78%) ▼|UNH364.69-2.39 (-0.65%) ▼|UNP270.44-1.69 (-0.62%) ▼|UPS93.99+0.55 (+0.58%) ▲|USB56.77-1.00 (-1.72%) ▼|V358.96-0.37 (-0.10%) ▼|VZ46.01+0.14 (+0.29%) ▲|WFC79.51-0.54 (-0.67%) ▼|WMT104.87+0.95 (+0.91%) ▲|XOM163.83+1.08 (+0.66%) ▲|
25.6 C
New York
Thursday, October 1, 2026

globenewswire

Author's Latest

Winner of the “Biotherapies and Bioproduction” call for projects under the France 2030 plan, EVerZom receives €3 million in government funding to industrialize its...

Winner of the “Biotherapies and Bioproduction” call for projects under the France 2030 plan, EVerZom receives €3 million in government funding to industrialize its exosome bioproduction technology

Epigenetics Diagnostics Market Analysis 2025-2034: Oncology Led with 68.7% Share in 2024, Driven by Demand for Early and Precise Cancer Detection Through Epigenetic Markers

The market, dominated by DNA methylation, sees significant contributions from North America, with the U.S. leading. Major players include Thermo Fisher Scientific, Illumina, and Roche Diagnostics, focusing on innovative tools that enhance precision medicine. 
The market, dominated by DNA methylation, sees significant contributions from North America, with the U.S. leading. Major players include Thermo Fisher Scientific, Illumina, and Roche Diagnostics, focusing on innovative tools that enhance precision medicine.

Form 8.3 – Dowlais Group plc

FORM 8.3

STMicroelectronics : Avec sa nouvelle solution de détection de présence humaine, STMicroelectronics améliore l’expérience des utilisateurs d’ordinateurs portables et de bureau

Avec sa nouvelle solution de détection de présence humaine, STMicroelectronics améliore l’expérience des utilisateurs d’ordinateurs portables et de bureau

DEADLINE ALERT for IOVA, DNUT, and MSTR: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

LOS ANGELES, June 17, 2025 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.

Llusern Scientific Announces ISO 13485 Certification for its Point-of-Care Diagnostics System for Urinary Tract Infections

CARDIFF, United Kingdom, June 17, 2025 (GLOBE NEWSWIRE) -- Llusern Scientific, a point-of-care diagnostics company, announces it has been awarded ISO 13485 certification for its Lodestar DX testing system, a rapid molecular diagnostic platform for urinary tract infections (UTIs). With industry-leading accuracy and speed, Lodestar DX empowers clinicians to diagnose and rule-out infections with precision in a single visit, thereby improving patient outcomes.

Captain T Cell Joins Bayer Co.Lab Berlin to Accelerate Autologous and Allogeneic TCR-T Cell Therapy Programs for Cancer Patients

Berlin, Germany – June 17th, 2025 – Captain T Cell GmbH, a biotech company developing next-generation TCR-based cell therapies for patients with solid tumors, today announced that it has been selected for residency in the Bayer Co.Lab incubator in Berlin.

Transactions by persons discharging managerial responsibilities and persons closely associated with them

Disclosure 9 / 2025

Evosep Joins P4ML to Power World’s Largest Multi-Omic Human Health Study of Two Million Samples

Evosep, a global leader in robust, high-throughput proteomics technologies, has been selected as the proteomics platform provider for the P4ML - OMICAssist

Kalmar introduces Automation as a Service – a model focused on adding long-term value for customers

KALMAR CORPORATION, TRADE PRESS RELEASE, 17 JUNE 2025 AT 10:00 AM (EEST)

Everfield Enters Denmark with Acquisition of Hospitality Software Leader OnlinePOS

Everfield acquires Danish hospitality software provider OnlinePOS. The deal strengthens Everfield's European food & hospitality software ecosystem.

FirstFarms’ top management is in position

The board has recruited internally for the CEO position.

FirstFarms’ topledelse er på plads

Bestyrelsen har rekrutteret internt til CEO-posten.

2025 Venture Awards Celebrate Startups Partnering with Stellantis to Enhance Customer Experience

2025 Venture Awards Celebrate Startups Partnering with Stellantis to Enhance Customer Experience

- A word from our sponsors -

spot_img

Follow us

HomeAuthorsPosts by globenewswire

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers